TY  - CHAP
AU  - Mark A. Feitelson
AU  - Alla Arzumanyan
AU  - Tiffany Friedman
AU  - N. Lale Tufan
AU  - Zhaorui Lian
AU  - Marcia M. Clayton
AU  - Joyce Kang
AU  - Helena M. G. P. V. Reis
AU  - Jingbo Pan
AU  - Jie Liu
AU  - Patrick Arbuthnot
AU  - Michael Kew
AU  - 
ED  - Wan-Yee Lau
Y1  - 2012-02-10
PY  - 2012
T1  - Mechanisms of HBx Mediated Liver Cancer: Multiple Pathways and Opportunities
N2  - Hepatocellular Carcinoma represents a leading cause of cancer death and a major health problem in developing countries where hepatitis B infection is prevalent. It has also become increasingly important with the increase in hepatitis C infection in developed countries.
Knowledge of hepatocellular carcinoma has progressed rapidly. This book is a compendium of papers written by experts to present the most up-to-date knowledge on hepatocellular carcinoma.
This book deals mainly with the basic research aspect of hepatocellular carcinoma. The book is divided into three sections: (I) Biomarkers / Therapeutic Target; (II) Carcinogenesis / Invasion / Metastasis; and (III) Detection / Prevention / Prevalence. There are 18 chapters in this book.
This book is an important contribution to the basic research of hepatocellular carcinoma. The intended readers of this book are scientists and clinicians who are interested in research on hepatocellular carcinoma. Epidemiologists, pathologists, hospital administrators and drug manufacturers will also find this book useful.
BT  - Hepatocellular Carcinoma
SP  - Ch. 14
UR  - https://doi.org/10.5772/27962
DO  - 10.5772/27962
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-18
ER  -